Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ABEOABEONA THERAPEUTICS INC.

Nasdaq · CIK 0000318306
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts446

Identity from submissions API

NameABEONA THERAPEUTICS INC.
CIK0000318306
TickersABEO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN830221517
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone646-813-4701
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • PLASMATECH BIOPHARMACEUTICALS INC (2014-09-22T04:00:00.000Z → 2015-06-04T04:00:00.000Z)
  • ACCESS PHARMACEUTICALS INC (1996-04-01T05:00:00.000Z → 2014-08-14T04:00:00.000Z)
  • CHEMEX PHARMACEUTICALS INC (1995-11-14T05:00:00.000Z → 1996-02-05T05:00:00.000Z)
Business address
6555 CARNEGIE AVE, 4TH FLOOR
CLEVELAND
OH
44103
OH
Mailing address
6555 CARNEGIE AVE, 4TH FLOOR
CLEVELAND
OH
44103
OH

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1323 filing rows loaded from submissions recent; extra archives: CIK0000318306-submissions-001.json (323 filings, 1995-08-15 to 2008-12-01).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 S-3 S-3 0001493152-26-053066 333-300134 261570574 33 985609 1 1
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001999371-26-025509 005-33655 261561541 34 16377
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128285 005-33655 261560773 34 15647
2026-11-16 4 4 0001493152-26-052027 4973
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002073679-26-000173 005-33655 261554640 34 66819
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001099910-26-000305 005-33655 261545681 34 6760
2026-11-09 10-Q 10-Q 0001493152-26-050738 001-15771 261536479 34 7752235 1 1
2026-11-09 8-K 8-K 2.02,7.01,9.01 0001493152-26-050609 001-15771 261533710 34 6594861 1 1
2026-11-09 8-K 8-K 1.01,2.01,3.02,7.01,9.01 0001493152-26-050606 001-15771 261533697 34 14790658 1 1
2026-10-23 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001477932-26-006433 005-33655 261481811 34 72376
2026-09-29 4 4 0001493152-26-044974 5677
2026-09-29 4 4 0001493152-26-044973 5715
2026-09-29 4 4 0001493152-26-044972 5714
2026-09-29 4 4 0001493152-26-044971 5721
2026-09-29 144 xsl144X01/primary_doc.xml 0001972481-26-000289 001-15771 261424574 33 5336
2026-09-29 144 xsl144X01/primary_doc.xml 0001972481-26-000288 001-15771 261424509 33 5285
2026-09-29 144 xsl144X01/primary_doc.xml 0001972481-26-000287 001-15771 261424506 33 5316
2026-09-29 144 xsl144X01/primary_doc.xml 0001972481-26-000286 001-15771 261424488 33 5367
2026-09-15 8-K 8-K 7.01,9.01 0001493152-26-042702 001-15771 261379830 34 5173391 1 1
2026-09-01 4 4 0001493152-26-041068 5497
2026-09-01 144 xsl144X01/primary_doc.xml 0001972481-26-000270 001-15771 261350847 33 5151
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005538 005-33655 261282301 34 13700
2026-08-13 10-Q 10-Q 0001493152-26-037576 001-15771 261270059 34 7902862 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001493152-26-037575 001-15771 261270054 34 305772 1 1
2026-07-22 4 4 0001493152-26-034246 5192
2026-07-10 424B3 424B3 0001493152-26-032852 333-268619 261169062 33 52677
2026-07-09 4 4 0001493152-26-032746 5712
2026-07-09 4 4 0001493152-26-032744 5673
2026-07-09 4 4 0001493152-26-032742 5711
2026-07-09 4 4 0001493152-26-032740 5707
2026-07-09 144 xsl144X01/primary_doc.xml 0001972481-26-000232 001-15771 261165870 33 5853
2026-07-09 144 xsl144X01/primary_doc.xml 0001972481-26-000231 001-15771 261165850 33 6489
2026-07-09 144 xsl144X01/primary_doc.xml 0001972481-26-000230 001-15771 261165814 33 5887
2026-07-09 144 xsl144X01/primary_doc.xml 0001972481-26-000229 001-15771 261165794 33 5885
2026-07-06 144 xsl144X01/primary_doc.xml 0001972481-26-000224 001-15771 261156003 33 5363
2026-07-02 4 4 0001493152-26-031906 5494
2026-06-26 S-8 S-8 0001493152-26-030313 333-297074 261129918 33 261984 1 1
2026-06-17 4 4 0001493152-26-029092 5197
2026-06-15 4 4 0001493152-26-028777 5738
2026-06-15 144 xsl144X01/primary_doc.xml 0001972481-26-000201 001-15771 261091552 33 4743
2026-06-12 8-K 8-K 5.07 0001493152-26-028458 001-15771 261087245 34 217498 1 1
2026-06-12 8-K 8-K 5.02 0001493152-26-028369 001-15771 261084915 34 196769 1 1
2026-06-10 8-K 8-K 7.01,9.01 0001493152-26-028106 001-15771 261079856 34 25689348 1 1
2026-06-09 4 4 0001493152-26-028019 7736
2026-06-09 4 4 0001493152-26-028022 9915
2026-06-09 4 4 0001493152-26-028021 7742
2026-06-09 4 4 0001493152-26-028020 7701
2026-06-09 144 xsl144X01/primary_doc.xml 0001972481-26-000188 001-15771 261077209 33 5891
2026-06-08 144 xsl144X01/primary_doc.xml 0001972481-26-000187 001-15771 261073977 33 5280
2026-06-08 144 xsl144X01/primary_doc.xml 0001972481-26-000186 001-15771 261073972 33 4683
2026-06-08 144 xsl144X01/primary_doc.xml 0001972481-26-000185 001-15771 261073970 33 5249
2026-06-08 144 xsl144X01/primary_doc.xml 0001972481-26-000184 001-15771 261073969 33 5297
2026-06-04 8-K 8-K 8.01 0001493152-26-027197 001-15771 261063210 34 202939 1 1
2026-05-26 4 4 0001493152-26-025258 4948
2026-05-22 4 4 0001493152-26-025085 5494
2026-05-22 144 xsl144X01/primary_doc.xml 0001972481-26-000166 001-15771 261013882 33 4585
2026-05-15 4 4 0001493152-26-023912 5674
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062715 005-33655 26989055 34 11727
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062655 005-33655 26988625 34 8028
2026-05-15 144 xsl144X01/primary_doc.xml 0001972481-26-000161 001-15771 26988349 33 5238
2026-05-13 10-Q 10-Q 0001493152-26-022614 001-15771 26970957 34 7626228 1 1
2026-05-13 8-K 8-K 2.02,9.01 0001493152-26-022610 001-15771 26970940 34 6817747 1 1
2026-05-11 4 4 0001493152-26-022332 5716
2026-05-11 144 xsl144X01/primary_doc.xml 0001972481-26-000150 001-15771 26963453 33 4675
2026-05-04 DEFA14A DEFA14A 0001493152-26-021127 001-15771 26938711 34 1104922
2026-04-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-019340 005-33655 26908012 34 9568
2026-04-27 ARS ARS 0001493152-26-019156 001-15771 26901502 34 1120558
2026-04-27 DEF 14A DEF 14A 0001493152-26-019153 001-15771 26901473 34 4431057 1 1
2026-04-17 PRE 14A PRE 14A 0001493152-26-017879 001-15771 26871997 34 3652297 1 1
2026-04-07 4 4 0001493152-26-015456 5124
2026-04-07 3 3 0001493152-26-015453 28064
2026-04-07 8-K 8-K 5.02,7.01,9.01 0001493152-26-015451 001-15771 26843044 34 228967 1 1
2026-04-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002073679-26-000044 005-33655 26842408 34 102660
2026-03-31 4 4 0001493152-26-014418 5669
2026-03-31 144 xsl144X01/primary_doc.xml 0001972481-26-000122 001-15771 26822843 33 5333
2026-03-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001099910-26-000139 005-33655 26806038 34 6697
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000362 005-33655 26794580 34 7459
2026-03-20 8-K 8-K 5.03,9.01 0001493152-26-011863 001-15771 26778634 34 211882 1 1
2026-03-17 10-K 10-K 0001493152-26-010413 001-15771 26759096 34 12917613 1 1
2026-03-17 8-K 8-K 2.02,9.01 0001493152-26-010408 001-15771 26759090 34 287586 1 1
2026-03-16 144 xsl144X01/primary_doc.xml 0001972481-26-000102 001-15771 26757278 33 5270
2026-03-16 4 4 0001493152-26-010276 5066
2026-03-09 8-K 8-K 8.01,9.01 0001493152-26-009299 001-15771 26733189 34 249118 1 1
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000906 005-33655 26623690 34 12403
2026-02-09 144 xsl144X01/primary_doc.xml 0001972481-26-000048 001-15771 26611389 33 4745
2026-02-04 4 4 0001493152-26-005106 5600
2026-02-02 4 4 0001493152-26-004807 5578
2026-02-02 4 4 0001493152-26-004805 5542
2026-02-02 144 xsl144X01/primary_doc.xml 0001972481-26-000040 001-15771 26588742 33 4721
2026-02-02 144 xsl144X01/primary_doc.xml 0001972481-26-000039 001-15771 26588569 33 4679
2026-02-02 144 xsl144X01/primary_doc.xml 0001972481-26-000037 001-15771 26588525 33 5867
2026-02-02 144 xsl144X01/primary_doc.xml 0001972481-26-000036 001-15771 26588509 33 4682
2026-02-02 4 4 0001493152-26-004761 5546
2026-02-02 4 4 0001493152-26-004759 5549
2026-01-27 4 4 0001493152-26-003810 5015
2026-01-27 4 4 0001493152-26-003809 4983
2026-01-27 4 4 0001493152-26-003808 4979
2026-01-27 4 4 0001493152-26-003807 5037
2026-01-27 4 4 0001493152-26-003806 4977
2026-01-27 4 4 0001493152-26-003805 5005
2026-01-27 4 4 0001493152-26-003804 4987
2026-01-27 4 4 0001493152-26-003803 4983
2026-01-26 4 4 0001493152-26-003611 7251
2026-01-26 3 3 0001493152-26-003608 30390
2026-01-22 4 4 0001493152-26-003284 5574
2026-01-22 4 4 0001493152-26-003283 5535
2026-01-22 4 4 0001493152-26-003282 5573
2026-01-22 144 xsl144X01/primary_doc.xml 0001972481-26-000031 001-15771 26551649 33 4674
2026-01-22 144 xsl144X01/primary_doc.xml 0001972481-26-000030 001-15771 26551646 33 4680
2026-01-22 144 xsl144X01/primary_doc.xml 0001972481-26-000029 001-15771 26551644 33 4680
2026-01-22 144 xsl144X01/primary_doc.xml 0001972481-26-000028 001-15771 26551641 33 5239
2026-01-21 4 4 0001493152-26-003094 5358
2026-01-21 144 xsl144X01/primary_doc.xml 0001972481-26-000025 001-15771 26547920 33 5175
2026-01-20 4 4 0001493152-26-002889 5063
2026-01-20 4 4 0001493152-26-002887 5024
2026-01-20 4 xslF345X05/ownership.xml 0001493152-26-002885 5047
2025-12-29 4 xslF345X05/ownership.xml 0001493152-25-029384 5556
2025-12-29 144 xsl144X01/primary_doc.xml 0001972481-25-000324 001-15771 251609033 33 6513
2025-11-14 4 4 0001493152-25-023532 5359
2025-11-13 144 xsl144X01/primary_doc.xml 0001972481-25-000268 001-15771 251478390 33 4570
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004895 005-33655 251475763 34 13246
2025-11-12 10-Q 10-Q 0001493152-25-021723 001-15771 251468877 34 7334982 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001493152-25-021721 001-15771 251468849 34 294886 1 1
2025-10-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000059 005-33655 251434263 34 6462
2025-10-16 4 4 0001493152-25-018311 5028
2025-10-16 144 xsl144X01/primary_doc.xml 0001972481-25-000252 001-15771 251397722 33 5821
2025-10-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-097132 005-33655 251377216 34 11914
2025-10-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-097130 005-33655 251377186 34 8005
2025-10-01 4 xslF345X05/ownership.xml 0001493152-25-016544 5558
2025-10-01 4 4 0001493152-25-016543 7754
2025-10-01 4 4 0001493152-25-016542 5574
2025-09-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002089521-25-000001 005-33655 251361809 34 205509
2025-09-29 144 xsl144X01/primary_doc.xml 0001972481-25-000220 001-15771 251356991 33 5298
2025-09-29 144 xsl144X01/primary_doc.xml 0001972481-25-000219 001-15771 251356821 33 5173
2025-09-29 144 xsl144X01/primary_doc.xml 0001972481-25-000218 001-15771 251356577 33 6368
2025-09-22 4 xslF345X05/ownership.xml 0001493152-25-014527 5049
2025-09-22 144 xsl144X01/primary_doc.xml 0001972481-25-000216 001-15771 251330369 33 5178
2025-08-15 4 4 0001641172-25-024384 5542
2025-08-15 4 4 0001493152-25-012099 5382
2025-08-15 144 xsl144X01/primary_doc.xml 0001972481-25-000173 001-15771 251224803 33 6352
2025-08-14 10-Q 10-Q 0001641172-25-023716 001-15771 251214358 34 7507283 1 1
2025-08-14 8-K 8-K 2.02,9.01 0001641172-25-023715 001-15771 251214353 34 330271 1 1
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-004720 005-33655 251213676 34 17871
2025-07-22 4 xslF345X05/ownership.xml 0001641172-25-020575 5558
2025-07-22 144 xsl144X01/primary_doc.xml 0001972481-25-000148 001-15771 251140420 33 5756
2025-07-18 8-K 8-K 1.01,2.03,9.01 0001641172-25-020227 001-15771 251134682 34 584540 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002982 005-33655 251132154 34 10998
2025-07-10 4 xslF345X05/ownership.xml 0001641172-25-018605 5586
2025-07-10 4 xslF345X05/ownership.xml 0001641172-25-018606 5521
2025-07-10 4 xslF345X05/ownership.xml 0001641172-25-018604 5560
2025-07-10 4 xslF345X05/ownership.xml 0001641172-25-018603 5563
2025-07-10 4 xslF345X05/ownership.xml 0001641172-25-018602 5554
2025-07-10 4 xslF345X05/ownership.xml 0001641172-25-018601 5558
2025-07-10 4 xslF345X05/ownership.xml 0001641172-25-018599 5535
2025-07-09 144 xsl144X01/primary_doc.xml 0001972481-25-000145 001-15771 251114108 33 5179
2025-07-09 144 xsl144X01/primary_doc.xml 0001972481-25-000144 001-15771 251114090 33 5745
2025-07-09 144 xsl144X01/primary_doc.xml 0001972481-25-000143 001-15771 251114063 33 5178
2025-07-09 144 xsl144X01/primary_doc.xml 0001972481-25-000142 001-15771 251114030 33 4592
2025-07-09 144 xsl144X01/primary_doc.xml 0001972481-25-000141 001-15771 251114017 33 4633
2025-07-09 144 xsl144X01/primary_doc.xml 0001972481-25-000140 001-15771 251113970 33 5766
2025-07-08 144 xsl144X01/primary_doc.xml 0001972481-25-000138 001-15771 251111114 33 4702
2025-07-02 8-K 8-K 2.01,2.02,8.01,9.01 0001641172-25-017460 001-15771 251098330 34 257078 1 1
2025-06-09 4 xslF345X05/ownership.xml 0001641172-25-014321 5036
2025-06-06 4 4 0001641172-25-014178 5573
2025-06-06 4 4 0001641172-25-014172 5534
2025-06-06 4 4 0001641172-25-014167 5568
2025-06-06 144 xsl144X01/primary_doc.xml 0001972481-25-000120 001-15771 251030809 33 4572
2025-06-06 144 xsl144X01/primary_doc.xml 0001972481-25-000119 001-15771 251030793 33 4568
2025-06-06 144 xsl144X01/primary_doc.xml 0001972481-25-000118 001-15771 251030772 33 5128
2025-06-03 4 xslF345X05/ownership.xml 0001641172-25-013428 5121
2025-05-27 4 xslF345X05/ownership.xml 0001641172-25-012556 4797
2025-05-27 144 xsl144X01/primary_doc.xml 0001972481-25-000101 001-15771 25989325 33 5158
2025-05-19 8-K 8-K 5.07 0001641172-25-011452 001-15771 25964100 34 212555 1 1
2025-05-16 4 xslF345X05/ownership.xml 0001641172-25-011289 5301
2025-05-16 144 xsl144X01/primary_doc.xml 0001972481-25-000093 001-15771 25959209 33 4584
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049535 005-33655 25954483 34 11205
2025-05-15 10-Q 10-Q 0001641172-25-010516 001-15771 25948732 34 6054455 1 1
2025-05-15 8-K 8-K 2.02,9.01 0001641172-25-010514 001-15771 25948714 34 361874 1 1
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002232 005-33655 25932833 34 13218
2025-05-12 8-K 8-K 1.01,8.01,9.01 0001641172-25-009564 001-15771 25932581 34 264134 1 1
2025-05-01 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-043520 005-33655 25903253 34 18494
2025-04-29 8-K FORM 8-K 7.01,9.01 0001641172-25-006584 001-15771 25882744 34 2959426 1 1
2025-04-29 8-K 8-K 8.01,9.01 0001641172-25-006548 001-15771 25882459 34 297680 1 1
2025-04-09 DEF 14A formdef14a.htm 0001641172-25-003411 001-15771 25825388 34 3716519 1 1
2025-03-31 4 xslF345X05/ownership.xml 0001641172-25-001922 5487
2025-03-31 144 xsl144X01/primary_doc.xml 0001972481-25-000063 001-15771 25793241 33 6306
2025-03-20 8-K form8-k.htm 2.02,9.01 0001493152-25-010981 001-15771 25754528 34 359609 1 1
2025-03-20 10-K form10-k.htm 0001493152-25-010978 001-15771 25754504 34 9228482 1 1
2025-03-17 4 xslF345X05/ownership.xml 0001493152-25-010591 5165
2025-03-04 4 xslF345X05/ownership.xml 0001493152-25-009056 5160
2025-02-03 4 xslF345X05/ownership.xml 0001493152-25-004751 5289
2025-02-03 4 xslF345X05/ownership.xml 0001493152-25-004750 5260
2025-02-03 4 xslF345X05/ownership.xml 0001493152-25-004754 5297
2025-02-03 4 xslF345X05/ownership.xml 0001493152-25-004752 5317
2025-02-03 4 xslF345X05/ownership.xml 0001493152-25-004753 5262
2025-02-03 4 xslF345X05/ownership.xml 0001493152-25-004755 5267
2025-02-03 4 xslF345X05/ownership.xml 0001493152-25-004748 5266
2025-02-03 4 xslF345X05/ownership.xml 0001493152-25-004749 5272
2025-01-31 4 xslF345X05/ownership.xml 0001493152-25-004437 5309
2025-01-29 144 xsl144X01/primary_doc.xml 0001972481-25-000018 001-15771 25569317 33 5160
2025-01-23 4 xslF345X05/ownership.xml 0001493152-25-003465 5048
2025-01-23 4 xslF345X05/ownership.xml 0001493152-25-003464 5053
2025-01-23 4 xslF345X05/ownership.xml 0001493152-25-003463 5014
2025-01-21 4 xslF345X05/ownership.xml 0001493152-25-003052 5309
2025-01-21 144 xsl144X01/primary_doc.xml 0001972481-25-000014 001-15771 25542536 33 4570
2025-01-06 S-8 forms-8.htm 0001493152-25-001051 333-284151 25512257 33 123458
2024-12-20 8-K form8-k.htm 5.02,5.07,9.01 0001493152-24-051060 001-15771 241568141 34 227870 1 1
2024-11-14 SC 13G/A ABEONA THERAPEUTICS INC. 0000902664-24-006667 005-33655 241465333 34 64891
2024-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-119142 005-33655 241463812 34 11232
2024-11-14 SC 13G/A JANUS CLOSEOUT 0001274173-24-000090 005-33655 241458015 34 12763
2024-11-14 10-Q form10-q.htm 0001493152-24-045340 001-15771 241457204 34 6539707 1 1
2024-11-14 8-K form8-k.htm 2.02,9.01 0001493152-24-045338 001-15771 241457201 34 334616 1 1
2024-11-12 DEF 14A formdef14a.htm 0001493152-24-044862 001-15771 241450013 34 1760763
2024-11-12 8-K form8-k.htm 8.01,9.01 0001493152-24-044514 001-15771 241443301 34 251784 1 1
2024-10-29 8-K form8-k.htm 8.01,9.01 0001493152-24-042775 001-15771 241402695 34 471284 1 1
2024-10-17 4 xslF345X05/ownership.xml 0001493152-24-041421 5126
2024-10-08 SC 13G/A ABEO_SC13GA2.htm 0001319244-24-000050 005-33655 241360628 34 96021
2024-09-30 4 xslF345X05/ownership.xml 0001493152-24-038800 5162
2024-09-30 4 xslF345X05/ownership.xml 0001493152-24-038802 5128
2024-09-30 4 xslF345X05/ownership.xml 0001493152-24-038799 5167
2024-09-24 4 xslF345X05/ownership.xml 0001493152-24-037961 5161
2024-08-27 4 xslF345X05/ownership.xml 0001493152-24-034058 5391
2024-08-27 4 xslF345X05/ownership.xml 0001493152-24-034056 5414
2024-08-27 4 xslF345X05/ownership.xml 0001493152-24-034054 5383
2024-08-27 4 xslF345X05/ownership.xml 0001493152-24-034052 5354
2024-08-27 4 xslF345X05/ownership.xml 0001493152-24-034050 5365
2024-08-27 4 xslF345X05/ownership.xml 0001493152-24-034048 5360
2024-08-14 4 xslF345X05/ownership.xml 0001493152-24-032395 5262
2024-08-14 4 xslF345X05/ownership.xml 0001493152-24-032393 5267
2024-08-14 3 xslF345X02/ownership.xml 0001493152-24-032383 3233
2024-08-14 3 xslF345X02/ownership.xml 0001493152-24-032381 3229
2024-08-14 8-K form8-k.htm 5.02,9.01 0001493152-24-031862 001-15771 241204171 34 244109 1 1
2024-08-12 10-Q form10-q.htm 0001493152-24-031150 001-15771 241194758 34 7140026 1 1
2024-08-12 8-K form8-k.htm 2.02,9.01 0001493152-24-031146 001-15771 241194749 34 355137 1 1
2024-07-22 4 xslF345X05/ownership.xml 0001493152-24-028697 5167
2024-07-09 4 xslF345X05/ownership.xml 0001493152-24-026649 5004
2024-07-09 4 xslF345X05/ownership.xml 0001493152-24-026646 5037
2024-07-09 4 xslF345X05/ownership.xml 0001493152-24-026648 5042
2024-07-09 4 xslF345X05/ownership.xml 0001493152-24-026647 5024
2024-07-09 4 xslF345X05/ownership.xml 0001493152-24-026644 4975
2024-07-09 4 xslF345X05/ownership.xml 0001493152-24-026645 4966
2024-07-09 4 xslF345X05/ownership.xml 0001493152-24-026641 4993
2024-07-09 4 xslF345X05/ownership.xml 0001493152-24-026643 4972
2024-07-09 4 xslF345X05/ownership.xml 0001493152-24-026642 5002
2024-07-09 8-K form8-k.htm 5.03,9.01 0001493152-24-026640 001-15771 241107757 34 362254 1 1
2024-06-21 424B5 form424b5.htm 0001493152-24-024767 333-280134 241061204 33 126788
2024-06-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-06-20 16:00:00 9999999995-24-001909 333-280134 241058293 33 2053
2024-06-20 4 xslF345X05/ownership.xml 0001493152-24-024528 5501
2024-06-20 4 xslF345X05/ownership.xml 0001493152-24-024527 5550
2024-06-17 CORRESP filename1.htm 0001493152-24-024177 13661
2024-06-17 S-3/A forms-3a.htm 0001493152-24-024171 333-280134 241049283 33 646457
2024-06-17 144 xsl144X01/primary_doc.xml 0001972481-24-000156 001-15771 241048938 33 4646
2024-06-17 144 xsl144X01/primary_doc.xml 0001972481-24-000155 001-15771 241048929 33 4592
2024-06-12 S-3 forms-3.htm 0001493152-24-023541 333-280134 241037485 33 1111055
2024-06-07 4 xslF345X05/ownership.xml 0001493152-24-023125 5168
2024-06-07 4 xslF345X05/ownership.xml 0001493152-24-023124 5128
2024-06-07 4 xslF345X05/ownership.xml 0001493152-24-023122 5163
2024-06-07 4 xslF345X05/ownership.xml 0001493152-24-023117 5161
2024-06-05 4 xslF345X05/ownership.xml 0001493152-24-022756 5126
2024-06-03 SC 13G/A p24-2014sc13ga.htm 0000902664-24-004011 005-33655 241014091 34 77310
2024-05-20 4 xslF345X05/ownership.xml 0001493152-24-020542 4803
2024-05-15 S-8 forms-8.htm 0001493152-24-019925 333-279428 24951744 33 108386
2024-05-15 10-Q form10-q.htm 0001493152-24-019459 001-15771 24947169 34 5812485 1 1
2024-05-15 8-K form8-k.htm 2.02,9.01 0001493152-24-019449 001-15771 24947153 34 313985 1 1
2024-05-13 SC 13G d11044802_13g.htm 0000919574-24-002863 005-33655 24940160 34 127055
2024-05-09 SC 13G JANUS HENDERSON GROUP PLC OWNS >%5 0001274173-24-000068 005-33655 24930050 34 13250
2024-05-08 4 xslF345X05/ownership.xml 0000902664-24-003378 10817
2024-05-03 8-K form8-k.htm 1.01,8.01,9.01 0001493152-24-017768 001-15771 24914408 34 1023845 1 1
2024-05-03 424B5 form424b5.htm 0001493152-24-017763 333-256850 24914337 33 475237
2024-05-03 8-K form8-k.htm 2.02,8.01 0001493152-24-017625 001-15771 24910733 34 212348 1 1
2024-04-29 4 xslF345X05/ownership.xml 0001493152-24-016853 4791
2024-04-29 4 xslF345X05/ownership.xml 0001493152-24-016852 4823
2024-04-26 4 xslF345X05/ownership.xml 0001493152-24-016064 4825
2024-04-26 4 xslF345X05/ownership.xml 0001493152-24-016062 5347
2024-04-24 8-K form8-k.htm 5.02,5.07,9.01 0001493152-24-015792 001-15771 24870551 34 236601 1 1
2024-04-22 8-K form8-k.htm 8.01,9.01 0001493152-24-015531 001-15771 24861199 34 244106 1 1
2024-03-19 DEF 14A formdef14a.htm 0001493152-24-010421 001-15771 24761084 34 1955481
2024-03-18 8-K form8-k.htm 2.02,9.01 0001493152-24-010206 001-15771 24757012 34 292408 1 1
2024-03-18 10-K form10-k.htm 0001493152-24-010190 001-15771 24756931 34 8363821 1 1
2024-03-15 4 xslF345X05/ownership.xml 0001493152-24-010132 5165
2024-03-12 4 xslF345X05/ownership.xml 0001493152-24-009682 5161
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023895 005-33655 24639800 34 59889
2024-02-14 SC 13G/A ABEONA THERAPEUTICS INC. 0000902664-24-001713 005-33655 24638703 34 62156
2024-02-14 SC 13G/A abeo13ga.htm 0000935836-24-000200 005-33655 24638436 34 47659
2024-02-14 SC 13G/A armistice-abeo123123a1.htm 0001172661-24-001247 005-33655 24636219 34 91004
2024-02-12 SC 13G/A e619238_sc13ga-at.htm 0001193805-24-000176 005-33655 24621363 34 104165
2024-02-07 4 xslF345X05/ownership.xml 0001493152-24-005208 5305
2024-01-22 4 xslF345X05/ownership.xml 0001493152-24-003193 5310
2024-01-10 SC 13G/A ABEO_SC13GA1_2024.htm 0001319244-24-000002 005-33655 24526831 34 96104
2024-01-08 8-K form8-k.htm 1.01,2.03,8.01,9.01 0001493152-24-001660 001-15771 24518348 34 1312886 1 1
2023-12-04 SC 13G ABEO_SC13G.htm 0001319244-23-000063 005-33655 231463098 34 95986
2023-11-27 8-K form8-k.htm 8.01,9.01 0001493152-23-042711 001-15771 231437319 34 240503 1 1
2023-11-13 10-Q form10-q.htm 0001493152-23-040323 001-15771 231395238 34 6099732 1 1
2023-11-13 8-K form8-k.htm 2.02,9.01 0001493152-23-040318 001-15771 231395128 34 291808 1 1
2023-10-18 8-K form8-k.htm 4.01,9.01 0001493152-23-037561 001-15771 231330921 34 299032 1 1
2023-10-17 4 xslF345X05/ownership.xml 0001493152-23-037500 5045
2023-10-10 S-8 forms-8.htm 0001493152-23-036752 333-274917 231318359 33 381704
2023-09-29 4 xslF345X05/ownership.xml 0001493152-23-034916 5047
2023-09-29 4 xslF345X05/ownership.xml 0001493152-23-034904 5085
2023-09-29 4 xslF345X05/ownership.xml 0001493152-23-034903 5081
2023-09-29 4 xslF345X05/ownership.xml 0001493152-23-034858 5473
2023-09-29 4 xslF345X05/ownership.xml 0001493152-23-034856 5424
2023-09-29 4 xslF345X05/ownership.xml 0001493152-23-034857 5441
2023-09-29 4 xslF345X05/ownership.xml 0001493152-23-034854 5419
2023-09-29 4 xslF345X05/ownership.xml 0001493152-23-034855 5414
2023-09-29 4 xslF345X05/ownership.xml 0001493152-23-034741 5224
2023-09-22 4 xslF345X05/ownership.xml 0001493152-23-033448 5080
2023-09-22 4 xslF345X05/ownership.xml 0001493152-23-033446 4944
2023-09-20 4 xslF345X05/ownership.xml 0001493152-23-033142 6224
2023-09-19 4 xslF345X05/ownership.xml 0001493152-23-033000 4744
2023-08-08 8-K form8-k.htm 2.02,9.01 0001493152-23-027107 001-15771 231149483 34 319536 1 1
2023-08-08 10-Q form10-q.htm 0001493152-23-027104 001-15771 231149342 34 5973153 1 1
2023-07-25 4 xslF345X05/ownership.xml 0001493152-23-025515 5085
2023-07-10 3 xslF345X02/ownership.xml 0000902664-23-003881 13920
2023-07-07 8-K form8-k.htm 8.01,9.01 0001493152-23-023908 001-15771 231075317 34 235870 1 1
2023-07-06 SC 13G/A ABEONA THERAPEUTICS INC. 0000902664-23-003838 005-33655 231074005 34 94475
2023-07-03 8-K form8-k.htm 1.01,8.01,9.01 0001493152-23-023235 001-15771 231063767 34 840087 1 1
2023-07-03 424B5 form424b5.htm 0001493152-23-023231 333-256850 231063744 33 343948
2023-06-21 4 xslF345X04/ownership.xml 0001493152-23-021996 4937
2023-06-16 4 xslF345X04/ownership.xml 0001493152-23-021652 4895
2023-06-16 4 xslF345X04/ownership.xml 0001493152-23-021653 4885
2023-06-16 4 xslF345X04/ownership.xml 0001493152-23-021650 4912
2023-06-16 4 xslF345X04/ownership.xml 0001493152-23-021648 4944
2023-06-16 4 xslF345X04/ownership.xml 0001493152-23-021649 4922
2023-06-16 4 xslF345X04/ownership.xml 0001493152-23-021651 4890
2023-06-07 4 xslF345X04/ownership.xml 0001493152-23-020417 4920
2023-06-07 4 xslF345X04/ownership.xml 0001493152-23-020416 4960
2023-06-07 4 xslF345X04/ownership.xml 0001493152-23-020415 4954
2023-06-07 424B5 form424b5.htm 0001493152-23-020412 333-256850 23999074 33 25653
2023-06-06 4 xslF345X04/ownership.xml 0001493152-23-020291 5127
2023-05-19 S-8 forms-8.htm 0001493152-23-018402 333-272103 23941498 33 261903
2023-05-17 8-K form8-k.htm 5.07 0001493152-23-017946 001-15771 23932161 34 227512 1 1
2023-05-11 10-Q form10-q.htm 0001493152-23-016278 001-15771 23908838 34 4765970 1 1
2023-05-11 8-K form8-k.htm 2.02,9.01 0001493152-23-016277 001-15771 23908833 34 286900 1 1
2023-05-05 4 xslF345X04/ownership.xml 0001493152-23-015587 4723
2023-04-19 ARS formars.pdf 0001493152-23-012907 001-15771 23830146 34 1756814
2023-04-13 DEF 14A formdef14a.htm 0001493152-23-012135 001-15771 23818517 34 1476615
2023-04-11 8-K form8-k.htm 5.02 0001493152-23-011838 001-15771 23813711 34 208012 1 1
2023-04-10 10-K/A form10-ka.htm 0001493152-23-011758 001-15771 23811825 34 494038 1 1
2023-04-05 4 xslF345X04/ownership.xml 0001493152-23-011036 5078
2023-03-29 424B5 form424b5.htm 0001493152-23-009464 333-256850 23775229 33 20122
2023-03-29 8-K form8-k.htm 2.02,9.01 0001493152-23-009382 001-15771 23771778 34 293784 1 1
2023-03-29 10-K form10-k.htm 0001493152-23-009381 001-15771 23771763 34 8483888 1 1
2023-03-22 S-8 forms-8.htm 0001493152-23-008534 333-270742 23752951 33 128364
2023-03-21 4 xslF345X04/ownership.xml 0001493152-23-008429 4968
2023-03-17 4 xslF345X03/ownership.xml 0001493152-23-008076 5080
2023-03-13 8-K form8-k.htm 7.01 0001493152-23-007341 001-15771 23725656 34 206302 1 1
2023-03-03 4 xslF345X03/ownership.xml 0001493152-23-006716 4932
2023-03-03 4 xslF345X03/ownership.xml 0001493152-23-006714 5075
2023-02-14 SC 13G SC 13G 0001104659-23-021927 005-33655 23631296 34 60832
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #2 0000899140-23-000398 005-33655 23629757 34 43130
2023-02-14 SC 13G armistice-abeo123122.htm 0001172661-23-001027 005-33655 23625019 34 90911
2023-02-10 SC 13G/A e618244_sc13ga-at.htm 0001193805-23-000140 005-33655 23609030 34 107912
2023-02-09 SC 13G/A ABEONA THERAPEUTICS INC. 0000902664-23-001363 005-33655 23605053 34 100246
2023-01-10 SC 13G/A formsc13ga.htm 0001493152-23-001091 005-33655 23521760 34 83829
2022-12-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-12-12 16:00:00 9999999995-22-003519 333-268619 221458437 33 2024
2022-12-12 4 xslF345X03/ownership.xml 0001493152-22-035169 4740
2022-12-06 CORRESP filename1.htm 0001493152-22-034587 12624
2022-12-05 UPLOAD filename1.pdf 0000000000-22-013087 40532
2022-12-01 S-3 forms-3.htm 0001493152-22-034055 333-268619 221436718 33 547758
2022-11-21 4 xslF345X03/ownership.xml 0001493152-22-033018 4745
2022-11-21 4 xslF345X03/ownership.xml 0001493152-22-033016 4740
2022-11-16 SC 13G e618034_sc13g-at.htm 0001193805-22-001560 005-33655 221395777 34 107639
2022-11-14 SC 13G abeonatherapeutics.htm 0000935836-22-000608 005-33655 221387094 34 47679
2022-11-14 10-Q form10-q.htm 0001493152-22-031655 001-15771 221380610 34 5150149 1 1
2022-11-14 8-K form8-k.htm 2.02,9.01 0001493152-22-031599 001-15771 221380293 34 306006 1 1
2022-11-10 SC 13G SCHEDULE 13G 0000899140-22-000784 005-33655 221374602 34 48766
2022-11-04 SC 13G formsc13g.htm 0001493152-22-030423 005-33655 221360828 34 88435
2022-11-03 8-K form8-k.htm 1.01,3.02,8.01,9.01 0001493152-22-030374 001-15771 221359179 34 987289 1 1
2022-11-03 8-K form8-k.htm 7.01,8.01,9.01 0001493152-22-030288 001-15771 221356241 34 3784595 1 1
2022-10-18 4 xslF345X03/ownership.xml 0001493152-22-028650 5042
2022-10-12 424B5 form424b5.htm 0001493152-22-028269 333-256850 221307315 33 18448
2022-09-30 4 xslF345X03/ownership.xml 0001493152-22-027279 4950
2022-09-30 4 xslF345X03/ownership.xml 0001493152-22-027280 5288
2022-09-30 4 xslF345X03/ownership.xml 0001493152-22-027277 4984
2022-09-28 4 xslF345X03/ownership.xml 0001493152-22-027054 5062
2022-09-28 4 xslF345X03/ownership.xml 0001493152-22-027052 5040
2022-09-28 4 xslF345X03/ownership.xml 0001493152-22-027051 5094
2022-09-28 4 xslF345X03/ownership.xml 0001493152-22-027048 5033
2022-09-28 4 xslF345X03/ownership.xml 0001493152-22-027047 4995
2022-09-28 4 xslF345X03/ownership.xml 0001493152-22-027045 4995
2022-09-28 4 xslF345X03/ownership.xml 0001493152-22-027042 5044
2022-09-28 4 xslF345X03/ownership.xml 0001493152-22-027041 5072
2022-09-22 4 xslF345X03/ownership.xml 0001493152-22-026569 5071
2022-08-31 S-8 forms-8.htm 0001493152-22-024500 333-267192 221218185 33 315095
2022-08-17 8-K form8-k.htm 5.07 0001493152-22-023332 001-15771 221174208 34 246216 1 1
2022-08-11 10-Q form10-q.htm 0001493152-22-021969 001-15771 221153724 34 5197168 1 1
2022-08-11 8-K form8-k.htm 2.02,9.01 0001493152-22-021966 001-15771 221153695 34 300163 1 1
2022-08-04 DEFA14A formdefa14a.htm 0001493152-22-021357 001-15771 221137554 34 20654
2022-07-25 4 xslF345X03/ownership.xml 0001493152-22-020281 4965
2022-07-20 8-K form8-k.htm 8.01,9.01 0001493152-22-019883 001-15771 221092845 34 225592 1 1
2022-07-19 424B5 form424b5.htm 0001493152-22-019857 333-256850 221092205 33 18460
2022-07-11 DEF 14A DEF 14A 0001140361-22-025707 001-15771 221077654 34 2798667
2022-06-30 8-K form8-k.htm 3.03,5.03,9.01 0001493152-22-018257 001-15771 221058644 34 233238 1 1
2022-06-17 4 xslF345X03/ownership.xml 0001493152-22-017168 5233
2022-06-17 4 xslF345X03/ownership.xml 0001493152-22-017159 5043
2022-06-14 8-K form8-k.htm 5.07 0001493152-22-016761 001-15771 221015643 34 210911 1 1
2022-06-07 4 xslF345X03/ownership.xml 0001493152-22-016079 5232
2022-05-19 8-K form8-k.htm 3.01,7.01,9.01 0001493152-22-014397 001-15771 22941157 34 237239 1 1
2022-05-17 8-K form8-k.htm 1.01,7.01,9.01 0001493152-22-014094 001-15771 22932290 34 301518 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (446 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 57.15M 2026-11-05 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
dei EntityPublicFloat Entity Public Float USD 273.25M 2025-06-30 2025 FY 10-K 2026-03-17 0001493152-26-010413
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.56M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001493152-26-019153
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.56M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001493152-26-019153
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 4.04M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001493152-26-019153
ecd PeoTotalCompAmt PeoTotalCompAmt USD 3.99M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001493152-26-019153
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 171.1 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001493152-26-019153
ffd NetFeeAmt NetFeeAmt USD 2,467.52 2026-11-18 S-3 2026-11-18 0001493152-26-053066
ffd TtlFeeAmt TtlFeeAmt USD 2,467.52 2026-11-18 S-3 2026-11-18 0001493152-26-053066
ffd TtlOfferingAmt TtlOfferingAmt USD 28.36M 2026-11-18 S-3 2026-11-18 0001493152-26-053066
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-18 S-3 2026-11-18 0001493152-26-053066
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-18 S-3 2026-11-18 0001493152-26-053066
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 1.05M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031655
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 3.00M 2025-12-31 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 15.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 43,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AccretionExpense Accretion Expense USD 1.01M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006705
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 5.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AccruedExchangeFeeRebateCurrent Accrued Exchange Fee Rebate, Current USD 3.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 27,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 11.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 2.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 43,000 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 19.28M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -229,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 909.68M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 7.00M 2021-12-21 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 9.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 3.67M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 4.91M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.33M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037576
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 5.25M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021723
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 29,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013174
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 12.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AreaOfLand Area of Land sqft 4,670 2023-04-30 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 1.80M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap Assets Assets USD 171.92M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AssetsCurrent Assets, Current USD 157.72M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 42.06M 2021-12-31 2022 Q3 10-Q 2022-11-14 0001493152-22-031655
us-gaap AssetsNet Net Assets USD 51.40M 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 68.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 138,000 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 229,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 68.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-09 0001493152-20-020812
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 2.60M 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 2.00M 2016-06-30 2016 Q2 10-Q 2016-08-15 0001144204-16-119452
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2016-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 301,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021723
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 66.28M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 68.61M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-16 0001144204-18-015277
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 84.50M 2025-03-31 2025 Q1 10-Q 2025-05-15 0001641172-25-010516
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 66.28M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 66.28M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -12.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2016-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/shares_unit 3.5 2009-12-31 2013 FY 10-K 2014-03-26 0000318306-14-000006
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 9.75 2021-12-21 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.79M 2021-12-21 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 5.76M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap CommonStockDividendsShares Common Stock Dividends, Shares shares 22,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0000318306-12-000057
us-gaap CommonStockOtherSharesOutstanding Common Stock, Other Shares, Outstanding shares 25 2022-06-30 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 57.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 57.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap CommonStockValue Common Stock, Value, Issued USD 572,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -42.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 409,000 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination USD 677,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 677,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 7.00M 2020-08-13 2020-08-14 2020 Q3 10-Q 2020-11-09 0001493152-20-020812
us-gaap ContractWithCustomerRefundLiability Contract with Customer, Refund Liability USD 1.50M 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 2.75M 2012-03-31 2012 Q1 10-Q 2012-05-15 0000318306-12-000036
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 2.75M 2011-06-30 2011 Q2 10-Q 2011-08-15 0000318306-11-000014
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 12.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020126
us-gaap CostsAndExpenses Costs and Expenses USD 83.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap CumulativeEffectOnRetainedEarningsNetOfTax1 Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) USD 6.28M 2018-01-01 2018-03-31 2019 Q3 10-Q 2019-11-12 0001493152-19-016905
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 11.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 12.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 3.50M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006705
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.01 2020-05-02 2020 Q2 10-Q 2020-08-10 0001493152-20-015077
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 28.00M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006705
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 186,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap DeferredRevenue Deferred Revenue USD 0 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 296,000 2021-12-31 2022 Q3 10-Q 2022-11-14 0001493152-22-031655
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 2.60M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001144204-18-027209
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 62,000 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD -92,000 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020126
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 652,000 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 76.53M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 770,000 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 34.40M 2017-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004015
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.60M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 65.96M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 310.70M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 5.20M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 91,000 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 1.00M 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsRegulatoryAssetsAndLiabilities Deferred Tax Assets, Regulatory Assets and Liabilities USD 318,000 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsStateTaxes Deferred Tax Assets, State Taxes USD 77,000 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness Deferred Tax Assets, Tax Credit Carryforwards, General Business USD 5.23M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.54M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 8.00M 2024-12-31 2024 FY 10-K 2025-03-20 0001493152-25-010978
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 107,000 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 5.48M 2022-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 74.92M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.60M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxLiabilitiesDerivatives Deferred Tax Liabilities, Derivatives USD 57,000 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004015
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1.33M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DeferredTaxLiabilitiesRegulatoryAssetsAndLiabilities Deferred Tax Liabilities, Regulatory Assets and Liabilities USD 271,000 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DefinedContributionPlanMaximumAnnualContributionPerEmployeeAmount Defined Contribution Plan, Maximum Annual Contribution Per Employee, Amount (Deprecated 2013-01-31) USD 17,500 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-26 0000318306-14-000006
us-gaap DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) pure 0.04 2011-01-01 2011-11-30 2012 FY 10-K 2013-03-20 0000318306-13-000004
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount USD 23,500 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap Depreciation Depreciation USD 700,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001493152-23-016278
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091600
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 313,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045340
us-gaap DerivativeLiabilities Derivative Liability USD 20.71M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037576
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 14.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 313,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020126
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 3.80M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091600
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-26 0000318306-14-000006
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 4.60M 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 4.16M 2022-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.86 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.506 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 984,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure -0.285 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 13.10M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045340
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091600
us-gaap EscrowDeposit Escrow Deposit USD 26.30M 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -4.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 1.69M 2019-06-30 2019 Q2 10-Q 2019-08-09 0001144204-19-038872
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 6.71M 2019-06-30 2019 Q2 10-Q 2019-08-09 0001144204-19-038872
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 8.52M 2019-06-30 2019 Q2 10-Q 2019-08-09 0001144204-19-038872
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 27.12M 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040323
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 801,000 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 801,000 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 116,000 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 29,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028506
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 117,000 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 117,000 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 117,000 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 116,000 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 2.16M 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040323
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 2,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap GainLossOnFairValueHedgesRecognizedInEarnings Gain (Loss) on Fair Value Hedges Recognized in Earnings USD 7.46M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040323
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 2,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 292,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 11.63M 2007-11-06 2007-11-07 2013 FY 10-K 2014-03-26 0000318306-14-000006
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 19.50M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001493152-26-022614
us-gaap Goodwill Goodwill USD 32.47M 2020-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 32.47M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap GrantsReceivable Grants Receivable USD 5.70M 2019-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004015
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 1.40M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031655
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 1.35M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap ImpairmentOfLeasehold Impairment of Leasehold USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 1.80M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031655
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 1.40M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap ImpairmentOfOngoingProject Impairment of Ongoing Project USD 3.30M 2022-01-01 2022-03-31 2022 Q2 10-Q 2022-08-11 0001493152-22-021969
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -42.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 102,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncomeTaxExaminationInterestExpense Income Tax Examination, Interest Expense USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap IncomeTaxExaminationPenaltiesExpense Income Tax Examination, Penalties Expense USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -36.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 34.42M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004015
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 14.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 112,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 141,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 619,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 14,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -679,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap IncomeTaxReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount USD -20.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 7.67M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -1.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 9.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncreaseDecreaseInAccruedTaxesPayable Increase (Decrease) in Accrued Taxes Payable USD -101,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 677,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 7.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001493152-26-022614
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-26 0000318306-14-000006
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -829,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -596,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -347,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -85,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -40,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001144204-18-058739
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -90,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 605,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -3.00M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013174
us-gaap IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities Increase (Decrease) in Restricted Investments for Operating Activities USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-26 0000318306-14-000006
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 8.05M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 614,251 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 176,221 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 2,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-16 0001144204-16-102610
us-gaap InterestAndOtherIncome Interest and Other Income USD 31,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-11 0001493152-22-021969
us-gaap InterestExpense Interest Expense USD 2.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap InterestExpenseOther Interest Expense, Other USD 200,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013174
us-gaap InterestIncomeOperating Interest Income, Operating USD 4.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 6,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap InterestPayableCurrent Interest Payable, Current USD 330,000 2012-09-13 2013 FY 10-K 2014-03-26 0000318306-14-000006
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 1.00M 2019-11-04 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap InventoryNet Inventory, Net USD 4.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 4.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 642,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037576
us-gaap InventoryWriteDown Inventory Write-down USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 551,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001144204-19-038872
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap LeaseCost Lease, Cost USD 1.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 5.82M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 834,000 2024-12-31 2024 FY 10-K 2025-03-20 0001493152-25-010978
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.33M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.39M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.39M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.36M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 325,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.04M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap Liabilities Liabilities USD 46.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 171.92M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap LiabilitiesCurrent Liabilities, Current USD 27.71M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 1.00M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020126
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001144204-18-027209
us-gaap LoansPayableCurrent Loans Payable, Current USD 330,000 2020-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap LongTermDebt Long-term Debt USD 11.85M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 11.85M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 7.78M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 5.18M 2024-12-31 2024 FY 10-K 2025-03-20 0001493152-25-010978
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 7.78M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 3.33M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 7.81M 2025-12-31 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 1.43M 2020-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap LossContingencyNumberOfDefendants Loss Contingency, Number of Defendants Defendant 30 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001144204-15-066026
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 78.63M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001144204-18-058739
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -8.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 85,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001144204-17-043141
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 42.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -84,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001144204-17-043141
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -45.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -10.84M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001144204-17-043141
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -42.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -12.00M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001641172-25-010516
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -42.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) USD 543,000 2018-04-01 2018-06-30 2019 Q2 10-Q 2019-08-09 0001144204-19-038872
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnDilutedEarningsPerShare New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Diluted Earnings Per Share (Deprecated 2020-01-31) USD 0.01 2018-04-01 2018-06-30 2019 Q2 10-Q 2019-08-09 0001144204-19-038872
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingResults New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Operating Results (Deprecated 2020-01-31) USD 543,000 2018-04-01 2018-06-30 2019 Q2 10-Q 2019-08-09 0001144204-19-038872
us-gaap NoncashContributionExpense Noncash Contribution Expense USD 699,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 30.00M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 42,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap NumberOfOperatingSegments Number of Operating Segments Integer 1 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006705
us-gaap NumberOfReportableSegments Number of Reportable Segments Integer 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OperatingExpenses Operating Expenses USD 42.92M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001641172-25-023716
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -49.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OperatingLeaseCost Operating Lease, Cost USD 850,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 900,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD -1.06M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 4.78M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.46M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.50M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap OperatingLeasePaymentsUse Operating Lease, Payments, Use USD 300,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 523,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 12.20M 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.74M 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.75M 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.74M 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.72M 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.71M 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 3.55M 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 858,000 2021-06-30 2021 Q2 10-Q 2021-07-28 0001493152-21-017978
us-gaap OperatingLeasesIncomeStatementLeaseRevenue Operating Leases, Income Statement, Lease Revenue USD 2.35M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 1.30M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.092 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 11.60M 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 1.79M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap OtherAssets Other Assets USD 139,000 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040323
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 827,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OtherCommitment Other Commitment USD 1.46M 2018-03-31 2018 Q1 10-Q 2018-05-10 0001144204-18-027209
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent USD 29,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -367,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 29,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0001493152-25-010978
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -367,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 1.35M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013174
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 2,000 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 200,000 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap OtherLoansPayableCurrent Other Loans Payable, Current USD 4.58M 2023-12-31 2024 FY 10-K 2025-03-20 0001493152-25-010978
us-gaap OtherNoncashExpense Other Noncash Expense USD 100,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001493152-23-016278
us-gaap OtherNoncashIncome Other Noncash Income USD 829,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001144204-19-038872
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -347,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006705
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 525,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-16 0001144204-18-015277
us-gaap OtherOperatingIncome Other Operating Income USD 141,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 403,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001493152-23-016278
us-gaap OtherReceivables Other Receivables USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 478,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap PaymentsForRent Payments for Rent USD 1.30M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004015
us-gaap PaymentsForRepurchaseOfConvertiblePreferredStock Payments for Repurchase of Convertible Preferred Stock USD 26.25M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap PaymentsForRoyalties Payments for Royalties USD 8.00M 2020-03-29 2020-04-02 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 963,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.50M 2021-12-20 2021-12-21 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 199,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006705
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 136.09M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 71.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 11.25 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 3.78M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091600
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2012-09-30 2012 Q3 10-Q 2012-11-14 0000318306-12-000057
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 16.00M 2021-12-20 2021-12-21 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 17.30M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 22.47M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 20.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-26 0000318306-14-000006
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 22.98M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0001493152-25-010978
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 80,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 10.50M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001641172-25-010516
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities USD 16.37M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001144204-18-058739
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.76M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006705
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 70.15M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 24.00M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-10 0001144204-19-025271
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 115.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 152.37M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 18,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 1.76M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 831,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031655
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 5.16M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ProgramRightsObligationsCurrent Program Rights Obligations, Current USD 8.00M 2020-04-17 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 28.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 9.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ReceivablesLongTermContractsOrPrograms Receivables, Long-term Contracts or Programs USD 1.50M 2022-06-30 2022 Q2 10-Q 2022-08-11 0001493152-22-021969
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 7.00M 2020-09-30 2020 Q3 10-Q 2020-11-09 0001493152-20-020812
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 8.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-26 0000318306-14-000006
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 18.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap RestrictedCash Restricted Cash USD 338,000 2024-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 338,000 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap RestrictedCashAndInvestmentsCurrent Restricted Cash and Investments, Current USD 330,000 2012-03-31 2012 Q1 10-Q 2012-05-15 0000318306-12-000036
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -784.15M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 33.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 3.42M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001144204-18-043278
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 2.55M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001144204-18-027209
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 300,000 2019-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004015
us-gaap Revenues Revenues USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001144204-19-038872
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 447,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap RoyaltyExpense Royalty Expense USD 100,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 50,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001144204-18-027209
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 16,474 2025-07-18 2026 Q2 10-Q 2026-08-13 0001493152-26-037576
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 9.75 2021-12-21 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020126
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 2.60M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001144204-18-027209
us-gaap SecuredDebtCurrent Secured Debt, Current USD 2.75M 2011-12-31 2013 FY 10-K 2014-03-26 0000318306-14-000006
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 52.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 30.00M 2021-11-12 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 9.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 15.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 13.72 2018-03-31 2018 Q1 10-Q 2018-05-10 0001144204-18-027209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.95 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.017 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 49,222 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 101,905 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 36 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 74,114 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 42.46 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 4.38M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028506
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.44 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028506
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 200 2026-03-31 2026 Q1 10-Q 2026-05-13 0001493152-26-022614
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 4 2026-03-31 2026 Q1 10-Q 2026-05-13 0001493152-26-022614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 101,905 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 36 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.86 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028506
us-gaap SharePrice Share Price USD/shares 6.07 2025-07-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap SharesOutstanding Shares, Outstanding shares 101.87M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028506
us-gaap ShortTermBorrowings Short-term Debt USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091600
us-gaap ShortTermInvestments Short-term Investments USD 68.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 44,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 125.88M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 1.10M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020126
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.79M 2021-12-20 2021-12-21 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 840,727 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-17 0001493152-21-011822
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 31.76M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-30 0001144204-17-017709
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091600
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 2.45M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 17.30M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 9.96M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045340
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 150,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014623
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -10,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD -4,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001493152-23-016278
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationForfeited Shares Issued, Value, Share-based Payment Arrangement, Forfeited USD 5,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 78,000 2019-04-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001144204-19-038872
us-gaap StockIssuedDuringPeriodValueStockDividend Stock Issued During Period, Value, Stock Dividend USD 3.78M 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-08 0001493152-23-027104
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 5.16M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap StockRedeemedOrCalledDuringPeriodShares Stock Redeemed or Called During Period, Shares shares 450,000 2019-05-14 2019-05-15 2019 FY 10-K 2020-03-16 0001493152-20-004015
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 26.30M 2022-06-16 2022-06-17 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 25.00M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010190
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 4.50M 2022-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009381
us-gaap TreasuryStockShares Treasury Stock, Shares shares 0 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020126
us-gaap TreasuryStockValue Treasury Stock, Value USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020126
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001144204-15-020126
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 39.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001493152-26-010413
us-gaap VariableLeaseCost Variable Lease, Cost USD 504,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 1.09M 2025-08-31 2025 Q3 10-Q 2025-11-12 0001493152-25-021723
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 13.58M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 57.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 98.44M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008259
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 57.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 57.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738
us-gaap WeightedAverageNumberOfSharesRestrictedStock Weighted Average Number of Shares, Restricted Stock shares 4.74M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050738

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →